Cancer Research Grants

As of July 2026, Grantoria lists 473 Cancer Research Grants — 322 open right now, across 20 funding agencies. Award amounts range $10K to $50M. The next application deadline is July 25, 2026. All listings are free, with direct links to the official application.

Not sure which grants fit your organization? Try the Grant Finder — match in 5 questions →

473total grants
322open now
20agencies
$10K–$50Mfunding range
Jul 25next deadline
OPEN 54 days left Very_hard to apply

NIH Director’s Pioneer Award (DP1 Clinical Trial Optional)

The NIH Director’s Pioneer Award supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on…

🏛 National Institutes of Health 📋 CFDA 93.310 ⏰ Sep 9, 2026 💰 $700,000 – $700,000
View details →
OPEN 59 days left Hard to apply

DoW Neurofibromatosis Research Academy – Leadership Award

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 14, 2026
View details →
OPEN Hard to apply

DoW Duchenne Muscular Dystrophy, Idea Development Award

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 18, 2026
View details →
OPEN Hard to apply

DoW Neurofibromatosis Synergistic Idea Award

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 22, 2026
View details →
OPEN Hard to apply

DoW Neurofibromatosis Exploration-Hypothesis Development Award

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 22, 2026
View details →
OPEN Hard to apply

DoW Neurofibromatosis Investigator-Initiated Research Award

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 22, 2026
View details →
OPEN Hard to apply

DoW Neurofibromatosis Research Academy – Scholar Award

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 22, 2026
View details →
OPEN Hard to apply

DoW Alzheimer’s Transforming Diagnosis Award

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 24, 2026
View details →
OPEN Hard to apply

DoW Alzheimer’s Transforming Research Award

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk…

🏛 Defense Health Agency Contracting Activity - DHACA 📋 CFDA 12.420 ⏰ Sep 24, 2026
View details →
OPEN Hard to apply

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis.…

🏛 National Institutes of Health 📋 CFDA 93.396 ⏰ Sep 25, 2026 💰 up to $1,700,000
View details →

Frequently asked questions

How many cancer research grants are available?
Grantoria currently lists 473 cancer research grants, of which 322 are open for applications right now. The database is refreshed daily from official federal sources (Grants.gov and SAM.gov).
When is the next deadline?
The next application deadline is July 25, 2026 — about 8 days away. Deadlines vary by program; open any grant to see its exact closing date and application window.
Who is eligible for cancer research grants?
Eligibility is set by each funding program, but cancer research grants in this category most often support: Public University, Private University, 501(c)(3) Public Charity and Small Business (SBA-defined). Check each grant's eligibility summary for the exact applicant types and requirements.
How much funding is available?
Award sizes range from $10K to $50M, depending on the program and applicant. Each grant shows its specific funding range where the agency has published one.
Is Grantoria free to use?
Yes — Grantoria is completely free. No account or subscription is required to browse cancer research grants, view deadlines and eligibility, or reach the official application.
How do I apply?
Open any grant to see its full profile — eligibility, required documents, deadlines and a direct link to the official application on the funding agency's website. You apply through the federal portal; Grantoria simply helps you find the right opportunity.

About Cancer Research grants

Cancer research grants support scientific investigations into prevention, detection, treatment, and survivorship across all cancer types. With 473 active grants currently listed, the National Institutes of Health and the Department of the Army's USAMRAA lead funding efforts in this critical field, driving innovation and advancing patient outcomes.

Award amounts typically range from $325,000 to $499,000, with all opportunities using competitive application processes. Public and private universities alongside nonprofit organizations are primary recipients. These grants fund research, capacity building, and pilot projects with no cost-sharing requirements. Filter by recipient type and support category to identify opportunities matching your institution's focus and expertise.